ADAR1 Capital Management LLC 13D and 13G filings for InMed Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-05 4:44 pm Purchase | 2026-05-31 | 13G | INMED PHARMACEUTICALS INC INM | ADAR1 Capital Management LLC | 800,000 24.100% | 800,000 (New Position) | Filing |